+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Glycomics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • PDF Icon


  • 117 Pages
  • January 2022
  • Region: Global
  • Mordor Intelligence
  • ID: 5332792

The glycomics market is expected to register a CAGR of 13.9% during the forecast period with the increasing research and development activities about glycomes and emerging technology for analysis of glycans and proteomes. Glycans, generally present on the cell surface, plays a very crucial role in the body system. They are responsible for many hereditary diseases and has a vital role in cancer development. Erythropoietin is a biological product used in anti-viral therapy and has three N-glycans and one O-glycan chain. Furthermore, in 2017, Sciex launched “Fast Glycan Labelling and Analysis Kit.” It saves time and effort for sample preparation, mostly used in the quantitative estimation of N-glycan. Hence, these factors are expected to drive the glycomics market growth. But the high cost of products related to glycomes may obstruct the glycomes market growth.

Key Market Trends

Drug Discovery and Development Segment is Expected to Hold a Major Market Share in the Glycomics Market

  • As the burden of chronic diseases is increasing, the need for developing new drugs is also increasing. Glycans play a major role in biological processes such as cell-cell interaction and thus have immense importance in drug development. Therefore, often these glycan chains are modified to synthesize drugs. For instance, hyaluronan, a naturally occurring disaccharide unit of glycosaminoglycan, has wide applications into medicine. It is used in post-surgical wounds and has an essential part in osteoarthritis treatment.
  • Furthermore, glycans have wide applications in vaccine development too. Many of the conjugate vaccines are based upon proteins and glycans. For instance, Prevnar 13 (manufactured by Pfizer, Inc.) used for preventing pneumococcal bacterial infection, is based upon glycans.
  • Thus, considering rising research and development, the market is expected to witness healthy CAGR over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region in the glycomics market owing to increasing research and development activities and government funding programs. Recently, the National Institute of Health-funded into the research “Computational and Informatics Resources and Tools for Glycoscience Research.” Furthermore, companies are investing heavily in research and development activities, which are expected to propel the growth of glycomics. According to Pharmaceutical Research and Manufacturers of America, in 2018, the pharmaceutical industry spent over USD 79.6 billion on research and development. Thus, it is expected to impact positively on North America’s glycomics market.

Competitive Landscape

The glycomics market is fragmented and consists of several major players. Companies are adopting growth strategies in order to develop the glycomics market. For instance, in 2018, Agilent Technologies, Inc. acquired ProZyme, Inc. to expand its product-line into glycome products. ProZyme Inc. is known for its glycobiology products and bioanalytical proteins. Some of the companies which are currently dominating the market are ThermoFisher Scientific Inc., Agilent Technologies Inc., Merck KGaA, Bruker, New England Biolabs Inc., Danaher (SCIEX), Takara Bio Inc., Waters Corporation, QA-Bio, and Shimadzu Corporation.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Assumptions
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Research and Development Activities in Glycomics
4.2.2 Technological Advancements in Products
4.3 Market Restraints
4.3.1 Complexity of Glycomics Coupled With The High Cost Involved in the Process
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Product Type
5.1.1 Instruments
5.1.2 Reagents and Kits
5.1.3 Enzymes
5.2 By Application
5.2.1 Drug Development
5.2.2 Diagnostics
5.2.3 Other Applications
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Rest of the World
6.1 Company Profiles
6.1.1 ThermoFisher Scientific Inc.
6.1.2 Agilent Technologies Inc.
6.1.3 Merck KGaA
6.1.4 Bruker
6.1.5 New England Biolabs Inc.
6.1.6 Danaher (SCIEX)
6.1.7 Takara Bio Inc.
6.1.8 Waters Corporation
6.1.9 QA-Bio
6.1.10 Shimadzu Corporation

Companies Mentioned

A selection of companies mentioned in this report includes:

  • ThermoFisher Scientific Inc.
  • Agilent Technologies Inc.
  • Merck KGaA
  • Bruker
  • New England Biolabs Inc.
  • Danaher (SCIEX)
  • Takara Bio Inc.
  • Waters Corporation
  • QA-Bio
  • Shimadzu Corporation